Glyburide, a medicine used to treat gestational diabetes in pregnant women, has been widely prescribed over the past decade, but a March 2015 study published by JAMA. Pediatrics has linked the drug to a higher risk of babies being admitted into the NICU with respiratory distress, hypoglycemia (low blood sugar), and other effects. The research also concludes that more birth injuries have resulted from mothers who were being treated with glyburide instead of insulin. With gestational diabetes doubling in the last 20 years, glyburide has become a popular treatment option. Authors of the study conclude that the “higher risk of neonatal outcomes associated with glyburide-treated women demands further attention,” and that more investigation into the drug’s effects is a “public health priority.”
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.